Response Biomedical's Q2 Revenues Slide 18 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Biomedical today reported an 18 percent drop in total revenues for the second quarter as contract service fees and revenues from collaborative research arrangements took a 79 percent hit.

For the three months ended June 30, the company posted revenues of $2.3 million, down from $2.7 million a year ago, while contract service fees and collaborative research-based revenues dropped to $143,089 from $668,221 in Q2 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.